Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Recruiting · NCT04684602 · Interventional (participants receive a specific treatment) · Lead sponsor: Thomas Advanced Medical LLC
View the official record on ClinicalTrials.gov →Interventions studied
PrimePro™/ PrimeMSK™
What this trial is about
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 1, Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 18 and older
- Ability to provide informed consent
- Availability for follow up visits
Exclusion criteria
- Active or recent malignancy (within last 2 years)
- Pregnancy or breast-feeding
- Inability to provide informed consent
Where it is running
1 location listed across 1 US state.
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites - Culver City, California, United States